Free shipping on all orders over $ 500

GW9508

Cat. No. M2020

All AbMole products are for research use only, cannot be used for human consumption.

GW9508 Structure
Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 55 In stock
10mg USD 50 In stock
50mg USD 160 In stock
100mg USD 275 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

GW9508 is a potent and selective G protein-coupled receptors FFA1 (GPR40) and GPR120 agonist with pEC50s of 7.32 and 5.46, respectively. GW9508 has anti-inflammatory and anti-atherosclerotic activities. GW9508 is a glucose-sensitive insulin secretagogue and an ATP-sensitive potassium (KATP) channels opener. GW9508 has anti-inflammatory and anti-atherosclerotic activities.

Customer Product Validations & Biological Datas
Source Exp Cell Res (2013). Figure 1. GW9508
Method XTT analyzes
Cell Lines MC3T3-E1 cell
Concentrations 1 10 50 100 μM
Incubation Time 24 h
Results To determine whether cell growth inhibition was related to cytostatic effects or cell death, OcP were labeled for apoptosis and necrosis pathways as determined by annexin V/7-AAD apoptosis detection kit. According to fluorescent activating cell sorting data, when incubated with 100 mM of GW9508, cells were found positive for both markers
Chemical Information
Molecular Weight 347.41
Formula C22H21NO3
CAS Number 885101-89-3
Solubility (25°C) DMSO ≥ 80 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Fujita T, et al. J Invest Dermatol. A GPR40 agonist GW9508 suppresses CCL5, CCL17, and CXCL10 induction in keratinocytes and attenuates cutaneous immune inflammation.

[2] Zhao YF, et al. J Endocrinol. Activation of ATP-sensitive potassium channels in rat pancreatic beta-cells by linoleic acid through both intracellular metabolites and membrane receptor signalling pathway.

[3] Briscoe CP, et al. Br J Pharmacol. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules.

Related GPR/FFAR Products
Fasiglifam (TAK-875) Hemihydrate

Fasiglifam (TAK-875) Hemihydrate is a novel, orally available, selective GPR40 agonist.

OC000459

OC000459 is a potent, selective, and orally active D prostanoid receptor 2 antagonist.

AMG-837

AMG 837 is a potent, orally bioavailable GPR40 agonist with EC50 of 14 nM.

AZD1981

AZD1981 is a potent, selective CRTh2 (DP2) receptor antagonist with IC50 of 4 nM, showing >1000-fold selectivity over more than 340 other enzymes and receptors, including DP1.

GSK1292263

GSK1292263 is a novel GPR119 agonist, showing potential for the treatment of type 2 diabetes.

  Catalog
Abmole Inhibitor Catalog




Keywords: GW9508 supplier, GPR/FFAR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.